{"name":"Sellas Life Sciences Group","slug":"sellas-life-sciences-group","ticker":"","exchange":"","domain":"sellaslifesciences.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":15674000,"netIncome":-26863000,"cash":78345000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2023"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"SLS009","genericName":"SLS009","slug":"sls009","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"SLS009","genericName":"SLS009","slug":"sls009","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxPcDNrdnNLbTQ4cGJMS2hnM0JSM3JSTmVtaVpmR0stMkZ2ZzYyOWJBMzR2S1lvUmUzSFZzX1JqZlZ0dy1VWUxXdXFTUmlZNXpnT1A2WFc0WXhIS2phSjZDTWMxSHZ2ZzRHVmF3SzVJankxNlVPbW1kNnBlOTJlZkFoTkdBZ2RQWXV2SG1PZ2szeGttNElVUWdVMUJDQWU4aWo4VTlUZVVjem9seEZaV0wxZGJXVko0bHRqWkxueXQwTEdiR2VtNHVwcng0OEQ2UUV3SzMzY3FXWktxZ3Q4eDJZTzZrT0M1WnF1T2tiZ0ZlaC11a3ZRTEJqYi1yN3ZFdWd2bjNuZS1IYVF1UWZHZ2FTMVF2dzA?oc=5","date":"2026-03-26","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Are Bullish on Top Healthcare Stocks: KalVista Pharmaceuticals (KALV), Achieve Life Sciences (ACHV) - The Globe and Mail","headline":"Analysts Are Bullish on Top Healthcare Stocks: KalVista Pharmaceuticals (KALV), Achieve Life Sciences (ACHV)","sentiment":"neutral"},{"date":"2026-03-19","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-19","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxPRExnTFgta0Jpa2daWm9BRlFOeWJwNjZUNC1Ld3lLLUJkWDc1S283OUJ0WHhCSmhQdkpzT2UwSDJEeUxrdnVVaktsSy05TnZOcDNHaS1GczFFUnppSEhCbFlENnYwcFp5Smo4RGtpVTBvb1hzN2dvMUJlTEZPcFBKd0FjT0pVbHZBSDN2NzRFS2tNS3VURkhWeTdwdHl2eTFkX1o4bXZYNVM0OHl5S2F0bXRfc3Z2NmNvZUVFQWhuSXE2TXdRazh0REprOG5HaFpTUkxQQkM0eDUteFBGcm4xVnE0bEtwYnFKSWtMMWR5aDJibHV4R3dTNGRRWGN3ejAzUkVDMFhSd29JOXhVaVBuNTZCQWhkWnFFRlNnNjJha1U?oc=5","date":"2026-03-11","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Cullinan Management (CGEM) and Pfizer (PFE) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Cullinan Management (CGEM) and Pfizer (P","sentiment":"neutral"},{"date":"2026-03-11","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-10","type":"trial","source":"Asianet Newsable","summary":"SLS Stock Rallies Ahead Of AML Trial Readout — ‘Pharma Bro’ Martin Shkreli Says He’s Still ‘Very Bearish,’ Predicts Drug Will Fail - Asianet Newsable","headline":"SLS Stock Rallies Ahead Of AML Trial Readout — ‘Pharma Bro’ Martin Shkreli Says He’s Still ‘Very Bearish,’ Predicts Drug","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxOek5ZRXU4ZUc3b1ZFaTBiMW15QnJTRnc4aWg0N3VMMG5vZTg2NU9udGlRdVVRT1hCbGlkQmQyUkJSV2NrTzN1ZUhRQ19fNDhLc2d2RmwtVjI3c3ktanFlZWE0Q1dtaHdXMUt0Y01KMnRZa1Nzc1RvTVR0aTczb2g3VTVRWEFpQmlpMXR3VmhPWUtwTjdLVXROMmM3QXJzYWJiNjRIYkRYQll4YmdpMnN4UEVTZFptVlVqUmZMRE5tb1JFa21rVFZLanNGaWVxU1JLQjBRcm56Vk8ybkpTcnM1NDJB?oc=5","date":"2026-03-09","type":"trial","source":"Stocktwits","summary":"SLS Stock Rallies Ahead Of AML Trial Readout — ‘Pharma Bro’ Martin Shkreli Says He’s Still ‘Very Bearish,’ Predicts Drug Will Fail - Stocktwits","headline":"SLS Stock Rallies Ahead Of AML Trial Readout — ‘Pharma Bro’ Martin Shkreli Says He’s Still ‘Very Bearish,’ Predicts Drug","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxPRG9pU0VtVTlFZVJvZUs5X0g1WWF3UDZzYnpaOV9EV2V5YlpVeTNRQjVhV3dFa3l4N2VWLVZValR3MGlkWHFSemJkLUdVdUQ4ZFFPcnpPcFV6V3ZhY0xjSG9xMDN3QnZOVGt0Yl9ZeFpGM0NWbHJBOHM3WlkwYk1ET1pGZzNndmI1ekhMUWtIdXZyMG1fRHhzTUlpMXdxMmRzNjVvSDViVWhQOEVZRUFwYjJSTG1vaVVjdzZVRURNSE1Ya2hQbWtOVnJQTjFWOVZSeEdnT05ERFlXakxfd2c?oc=5","date":"2026-03-05","type":"trial","source":"Stocktwits","summary":"SELLAS Life Sciences Group Stock Soars As It Nears Final Analysis In Cancer Study - Stocktwits","headline":"SELLAS Life Sciences Group Stock Soars As It Nears Final Analysis In Cancer Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxNNGVpUFhJZW9tODl4ZFRiMGM5NDljUW9LRHppUVM2bXBVbFhUMEVWX1RCanQ3dWt5WV9URl9zLVVaVVpJa0lIbUNNYTNnRGduRE5iTGoyeUlNSm9zQ2ROSkZDZmQ4QUF3R0cyWTIzcTFBX1BTRXRYLU5kSVBFdnJMNi1CX1dLWm5tdEdoLU5UUVplOFdhUEVuZ1pvX3JnZFRWYVgwY0RmV1JSdWhMZVhSdTBJX3VTZ25EYzhBUkl3NkpyRTdxNXZybXhoZ1NreTZ6RWgxb3FtSVVKSXJLVTRvVEZkME1zS2VKdUFGWVdlZENfUnd3d3owdjBnMkdfdC1y?oc=5","date":"2026-01-27","type":"pipeline","source":"The Globe and Mail","summary":"Hard-to-Treat Cancers: How 2026’s Top Clinical Platforms Are Beating Industry Benchmarks - The Globe and Mail","headline":"Hard-to-Treat Cancers: How 2026’s Top Clinical Platforms Are Beating Industry Benchmarks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPTDNxQ0JQd2pSLTBOaW5VUVlNOHV4blhGakdoNlgwWDVrMDE3VVh0Q0pDZF9HUkxsZmhEQ2dqSmlyNFVNNXJkRzgyUFBSV1E4S04yVnpaODdzYWpBTXFZblVObFNQVWttWjJld0E2bGd2NFQ0WUN5NXRBVnBZemZaWVdLVkczT2pNX2ljVFNuMllReVdFNjlaZUo3ak1NYVVIUFNrZEMtcWtsMmxZcS1nb1F1bmExU3JNWDlITXZIVzl0MkRZT3cySWlYQXVIb2lmZFI1Z0VKM2pmemwydEtSMg?oc=5","date":"2026-01-08","type":"pipeline","source":"GlobeNewswire","summary":"The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech - GlobeNewswire","headline":"The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech","sentiment":"neutral"},{"date":"2026-01-08","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQTlhfdld3QnVtNU5hVGRkYTFxQ0EyeThCU0c3WmZtM2VQMDhYM1dPbUhnbE0zMllzVmRFSHlmV2pMVExnMWJBUXpwVXRwdHJUNWhmUzgxMkhncVVYNjNfclY3MmtLV2NfUnJyYmRuRHJUeVFkOGdDRTZZbHZ3UmEtSmRQcDlRcWppZW1mNWRJOU9Ba0ZDRml3TTY0VU00VU1P?oc=5","date":"2025-12-30","type":"pipeline","source":"Investing News Network","summary":"Discover the Top 5 Small-Cap Biotech Stocks in 2025 - Investing News Network","headline":"Discover the Top 5 Small-Cap Biotech Stocks in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOQ1ZIOGRMT21nUDRUSUl3YkpxLVZ0UE5yRDhBOUJzSnFuQ0x6MngxRVlXVE45WDU1WTRJN09XNEwtbDFjRUhkd3pHbWNaS2R1WUo4QWV1aWkteXJ5c2dNQThHdTJOVDdGcm4tOFA0UWxFUENDRmM0bkZTT2pucnlJTUtUSUtyWENXQWc?oc=5","date":"2025-12-29","type":"trial","source":"StocksToTrade","summary":"Sellas Life Sciences Stock Surges After Positive Clinical Trials - StocksToTrade","headline":"Sellas Life Sciences Stock Surges After Positive Clinical Trials","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOdU1nc1hXZ193akxIR3lwSHduLVY1X0cwQnQ2VnZpY2lIM25SZkh4TVdwT3RfQnN0ZlZ2TkVhUWg2cVhrZkYxbjMyYlZucVdPOE9DM281cVpDXzZ2NkZpQVQ2ZVFyTHdRaUNZaGtSUldGVEYwYVlTZ08xc2k1eE9WblQ3UG9pOHQzMUM2V3R3MTNPdUJfQTNTY1BXYkRybkJXZVllUlFTeE9qYkowd1JJQTAxQi1HemJ5NkE?oc=5","date":"2025-09-30","type":"trial","source":"Stock Titan","summary":"Major AML Treatment Updates: SELLAS Life Sciences to Reveal Phase 3 REGAL Results & New Drug Progress - Stock Titan","headline":"Major AML Treatment Updates: SELLAS Life Sciences to Reveal Phase 3 REGAL Results & New Drug Progress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE4wQnVNTXRmTGYxWGl6cjBudG8ybXhFZldLbnBxYk4xZ1RMX1NmVlpoT3lyUGdOa0ZSbk50dDQ3cmgtcEZtQXVUZWtnaFJIQnRQLXc?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"SLS Stock Price, News & Analysis | Sellas Life Sciences Group - Stock Titan","headline":"SLS Stock Price, News & Analysis | Sellas Life Sciences Group","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2023-12-31","revenueHistory":[{"value":0,"period":"2023-12-31"},{"value":1000000,"period":"2022-12-31"},{"value":1000000,"period":"2022-12-31"},{"value":7600000,"period":"2021-12-31"},{"value":7600000,"period":"2021-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":15674000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-26863000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":78345000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}